HOME >> MEDICINE >> NEWS
Boston University School of Medicine faculty member receives honorary degree from alma mater

Boston Boston University School of Medicine (BUSM) researcher Dr. Philip Wolf was a recipient of the Honorary Degree, Doctor of Science from his alma mater, State University of New York, Upstate Medical University. Wolf received the degree at the Colleges recent commencement ceremonies in Syracuse, New York.

Wolf received his medical degree from the State University of New York College of Medicine at Syracuse in 1960 cum laude where he was elected to Alpha Omega Alpha. He was an intern in medicine at the former Boston City Hospital, an assistant resident in medicine at the Peter Bent Brigham Hospital and a resident in neurology and neuropathology at the Massachusetts General Hospital in Boston.

He trained in epidemiology and biostatistics at the University of Pennsylvania, Graduate School of Medicine and served as senior assistant surgeon in the Field Epidemiologic Research Section, National Heart Institute, of the United States Public Health Service. Following receipt of a research fellowship in neuroepidemiology from the NINCDS at the Massachusetts General Hospital, he joined the faculty of Boston University in 1969. He is a professor of neurology, research professor of medicine (epidemiology and preventive medicine) at BUSM, and professor of public health (epidemiology and biostatistics) at Boston University School of Public Health.

Since1989, he has been principal investigator on the National Heart, Lung and Blood Institute (NHLBI) Contract, The Framingham Study, Physical Examination, Testing and Surveillance awarded to BUSM; he was co-principal investigator from 1983 to 1989.

In 2002, after more than 30 years, he stepped down from the post of Chief of the Cerebrovascular Disease Section, Department of Neurology at Boston University Medical Center (BUMC). He has participated in a number of US and international cooperative clinical trials in stroke. He was a PI or Executive Committee member for several key projects
'"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University
23-May-2007


Page: 1 2

Related medicine news :

1. Childrens Hospital Boston presents at the American College of Cardiology Scientific Sessions
2. Boston Celtics fund first teen vaccination delivery program in the country
3. Childrens Hospital Boston neurosurgeons to perform brain tumor removal during live Web cast
4. Dr Elise Feng-I Morgan of Boston University receives 2005 IOF-Servier Young Investigator Award
5. Boston University and Boston Medical Center partner with CIMIT
6. UCSD/Boston University find antidepressants may affect fetus
7. Childrens Hospital Boston hosts live Webcast
8. Boston University psychologists find neurological mechanism for subliminal learning
9. Indiana University Imaging Center receives $6M grant for kidney research
10. University hospitals wins multiple national IT awards for electronic patient data bank
11. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University

Post Your Comments:
(Date:7/30/2015)... ... July 30, 2015 , ... The Clinical Data Interchange Standards ... to announce that data standards for clinical research in the areas of Schizophrenia, ... website . These three Therapeutic Area (TA) standards were developed per the CDISC ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... with Setria®Glutathione and Sustamine® L-Alanyl-L-Glutamine for people on the go. With no water ... Zaca Recovery Chewable as a simple way to get the natural ingredients that ...
(Date:7/30/2015)... Angeles, CA (PRWEB) , ... July 30, 2015 , ... ... cars on an upcoming dedicated web site. As discussed in a June 8, 2015 ... the minor collisions reported so far have been caused by its computer-driven cars, which ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... announce its position as one of Medicare’s top-rated care centers. The video ... the CMS rating system, which monitors health inspections, staffing, and quality measures. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a New Way ... Training Capability , World renown body weight trainer, Paul Ziachik, announces today ... dramatically increases a person’s training capability. , The American College of Sports Medicine ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
(Date:7/30/2015)... Wash. and VANCOUVER , ... OGXI ) announced today that it will report its ... 2015. Company management will host a conference call and ... an overview of financial results, clinical development programs and ... the webcast, log on to the Investor Relations page ...
(Date:7/30/2015)... OAKS, Calif. , July 30, 2015  Amgen (NASDAQ: ... Hassan , partner and managing director of Warburg Pincus LLC, ... are pleased to welcome Fred Hassan and the ... the Amgen Board," said Robert A. Bradway , chairman ... and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
Cached News: